![Kathryn Corzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn Corzo
Director/Board Member at
MARKER THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Kathryn Penkus Corzo is currently an Independent Director at Marker Therapeutics, Inc. since 2025.
Former positions include Independent Director at Matinas BioPharma Holdings, Inc. from 2021 to 2024; Director at Maverick Therapeutics, Inc. from 2020 to 2021; Head-Oncology Cell Therapy Development at Takeda Pharmaceutical Co., Ltd. from 2020 to 2021; Vice President at Genzyme Corp.
from 2010 to 2019; Director-Clinical Liaison & Medical Communications at Syndax Pharmaceuticals, Inc. from 2008 to 2010; Principal at Eli Lilly & Co. from 1989 to 2010; Principal at Hoffman-LaRoche F & Co. AG from 1989 to 2000; Partner at Takeda Ventures, Inc.; and President & Chief Operating Officer at Bit Bio Ltd. Education includes an undergraduate degree from Massachusetts College of Pharmacy & Health Science and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-28 | 0 ( -.--% ) | - $ | 2026-05-30 |
Kathryn Corzo active positions
| Companies | Position | Start |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Director/Board Member | 2025-10-31 |
Former positions of Kathryn Corzo
| Companies | Position | End |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 2024-11-21 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2021-09-30 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Director/Board Member | 2021-02-28 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 2018-12-31 |
| SYNDAX PHARMACEUTICALS, INC. | Public Communications Contact | 2010-01-24 |
Training of Kathryn Corzo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Bit Bio Ltd.
 Bit Bio Ltd. BiotechnologyHealth Technology Operates as a biology company that providing human cells for research, drug discovery and cell therapy | Health Technology |
- Stock Market
- Insiders
- Kathryn Corzo
